Millions of Americans have tried GLP-1 medications like Ozempic, Mounjaro and Wegovy, polls show, but pharmacy claims data show that many people stop taking them within less than one year
Jun 2007;9 Suppl 1:S83-92
At Mobile IV Nurses, we understand the impact of liver disease on your quality of life
Brello partner pharmacy follows state board regulations Pricing: Brello tends to be less expensive than most Empower-based providers Formulation options: Empower offers more formulation choices (with B12, glycine, NAD+, etc.) Reliability: Empower has a longer track record with fewer widespread shipping disruptions For a detailed dosing comparison, see our Empower tirzepatide dosage chart
Emerging reviews of the GLP-1 market anticipate continued demand, pipeline diversification, and health-system impact as agents move earlier in care pathways, reinforcing the case for meaningful market expansion through 2026-2028